APLS
Apellis Pharmaceuticals, Inc. · Healthcare · Biotechnology
Señales de momentum (gestores comparables):
amplitud de titulares -15.4% ·
flujo de acciones +4.7% ·
nuevas posiciones netas -18.2%
— fórmula
Acumulación concentrada — aumento de acciones entre menos titulares
Todas las cifras de propiedad: únicamente gestores 13F seguidos, posiciones en acciones ordinarias, período de referencia Q1 2025
| Trimestre | Titulares | Δ | Acciones | Valor declarado | Nuevo | Cierres |
|---|---|---|---|---|---|---|
| Q1 2026 | 99 | +3 | 79.10M | $3.12B | +14 | −12 |
| Q4 2025 | 97 | +1 | 73.39M | $1.84B | +2 | — |
| Q3 2025 | 19 | +1 | 50.24M | $1.14B | +1 | −1 |
| Q2 2025 | 16 | +2 | 43.69M | $756.24M | +2 | — |
| Q1 2025 | 11 | -2 | 24.93M | $545.30M | +1 | −3 |
| Q4 2024 | 13 | +2 | 23.82M | $760.24M | +3 | −1 |
| Q3 2024 | 10 | +2 | 20.37M | $587.46M | +2 | — |
| Q2 2024 | 8 | — | 21.17M | $811.69M | — | — |
| # | Gestor | Acciones | Δ acciones | Valor | Su ponderación | Mantenida | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Wellington Management ✦ | 12.30M | +4.3% | $269.07M | 0.1% | ▲ Add | 4 | SEC ↗ |
| 2 | Wellington Management ✦ | 12.30M | +4.3% | $269.07M | 0.1% | ▲ Add | 4 | SEC ↗ |
| 3 | Wellington Management ✦ | 12.30M | +4.3% | $269.07M | 0.1% | ▲ Add | 4 | SEC ↗ |
| 4 | Wellington Management ✦ | 12.30M | +4.3% | $269.07M | 0.1% | ▲ Add | 4 | SEC ↗ |
| 5 | Wellington Management ✦ | 12.30M | +4.3% | $269.07M | 0.1% | ▲ Add | 4 | SEC ↗ |
| 6 | AQR Capital Management ✦ | 4.08M | +119.6% | $89.17M | 0.1% | ▲ Add | 4 | SEC ↗ |
| 7 | AQR Capital Management ✦ | 4.08M | +119.6% | $89.17M | 0.1% | ▲ Add | 4 | SEC ↗ |
| 8 | AQR Capital Management ✦ | 4.08M | +119.6% | $89.17M | 0.1% | ▲ Add | 4 | SEC ↗ |
| 9 | AQR Capital Management ✦ | 4.08M | +119.6% | $89.17M | 0.1% | ▲ Add | 4 | SEC ↗ |
| 10 | AQR Capital Management ✦ | 4.08M | +119.6% | $89.17M | 0.1% | ▲ Add | 4 | SEC ↗ |
| 11 | State Street Global Advisors ✦ (pasivo) | 3.94M | -12.9% | $86.20M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 12 | Geode Capital Management ✦ (pasivo) | 1.95M | +6.0% | $42.66M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 13 | Geode Capital Management ✦ (pasivo) | 1.95M | +6.0% | $42.66M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 14 | Norges Bank ✦ (pasivo) | 1.57M | +44.9% | $34.41M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 15 | Millennium Management ✦ | 451.97K | -21.5% | $9.88M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 16 | Two Sigma Investments ✦ | 262.90K | Nuevo | $5.75M | 0.0% | New | 1 | SEC ↗ |
| 17 | Citadel Advisors ✦ | 224.10K | +99.3% | $4.90M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 18 | Citadel Advisors ✦ | 224.10K | +99.3% | $4.90M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 19 | T. Rowe Price ✦ | 90.70K | -74.7% | $1.98M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 20 | Gotham Asset Management ✦ | 34.28K | +41.1% | $749,813 | 0.0% | ▲ Add | 2 | SEC ↗ |
| 21 | Marshall Wace ✦ | 23.57K | -72.4% | $515,563 | 0.0% | ▼ Trim | 3 | SEC ↗ |
«Su ponderación» = la participación de la posición en el valor de renta variable 13F declarado por ese gestor — la medida de convicción. ✦ = gestor seleccionado.
Nuevos compradores
| Two Sigma Investments | $5.75M | 0.0% |
Posición cerrada
| Point72 Asset Management | $40.46M | era 0.1% |
| Renaissance Technologies | $8.68M | era 0.0% |
| D. E. Shaw & Co. | $638,200 | era 0.0% |
Contexto de mercado completo: entre TODOS los filers 13F (datos estructurados SEC, Q1 2026): 320 tenedores, 137.95M acciones, $5.43B declarado. Este es un período diferente y anterior al de las cifras del universo rastreado que figuran arriba, y ambos nunca se mezclan.
Qué otros valores suelen tener también los tenedores rastreados de este activo — recuentos de cotenencia, no relaciones fundamentales.